Investors
The share
| Friday, September 30, 2022 5:29 PM | +/- | % | Buy | Sell | Last | High | Low | Volume |
| ENZY (Stockholm) SEK/share | +0 | 0.00% | 3.25 | 3.31 | 3.31 | 3.31 | 3.25 | 29274 |
Share capital
At the end of 2021, the share capital of Enzymatica AB was SEK 5 972 977 SEK, distributed among 149 324 400 shares, each with a par value of SEK 0.04.
The Company has only one class of stock. Each share entitles the holder to one vote at Enzymatica’s general meeting of shareholders. Each shareholder who is entitled to vote may vote at the general meeting for the full number of shares that he or she owns and represents. Each share carries equal rights to a part of the Company’s assets and profit.
Dividend
The Board of Directors does not intend to propose any dividend until the Company generates a profit and a positive cash flow.
Ownership structure
Name | Number of shares | Percentage of capital and votes (%) |
Mats Andersson, privately and through Abanico Invest AB | 31 081 437 | 20,81% |
Håkan Roos, through Roosgruppen AB | 19 029 461 | 12,74% |
Björn Algkvist through Fibonacci Asset Management & Fibonacci Growth Capital | 16 227 416 | 10,87% |
Gudmundur Palmason, through Fortus hf company | 7 142 496 | 4,78 % |
Ágústa Gudmundsdottir | 5 190 679 | 3,48% |
Nordnet Pensionsförsäkring AB | 4 124 694 | 2,76% |
Aktiebolaget Possessor | 3 800 000 | 2,54% |
Avanza Pension Försäkring AB | 3 139 104 | 2,10 % |
Swedbank Försäkring | 2 573 954 | 1,72% |
Tom Stendahl | 2 526 658 | 1,69% |
Holdings 10 largest shareholders | 94 835 899 | 63,51% |
Other | 54 488 501 | 36,49 % |
Total | 149 324 400 | 100,0% |
Euroclear 30 June 2022
Analyses
During the year Enzymatica was analyzed by ABG Sundal Collier and Erik Penser Bank.
Rickard Anderkrans ABG Sundal Collier: rickard.anderkrans@abgsc.se
Johan Löchen, Penser: johan.lochen@penser.se